Treatment Selection and Sequencing in Late Multiple Myeloma Relapse

These case studies have been developed with the assistance of Brea Lipe, MD, Professor, Department of Medicine, Hematology/Oncology (SMD), University of Rochester Medical Center, and Shambavi Richard, MD, Associate Professor of Medicine, Director of Myeloma and Lymphoma, Mount Sinai School of Medicine/Icahn School of Medicine.

The information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional licence, experience and knowledge of the individual patient.

For full prescribing information, including indications, contraindications, warnings, precautions and adverse events, please refer to the approved product labelling. Please note that products may have different product labelling in other countries.

All characters and events depicted in this patient case simulation are entirely fictitious. Any similarity to actual events or persons, living or dead, is purely coincidental.

Previous
Previous

Evidence Based Management of Progressive MS

Next
Next

Decision Points in Chronic kidney disease (CKD)